Healthcare provider profile · identity verified

Harry J Schinder, MD

Family Practice · GLEN COVE, NY · NPI 1477651065

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	429	128
Simvastatin	Simvastatin	389	110
Alprazolam	Alprazolam	380	94
Levothyroxine Sodium	Levothyroxine Sodium	318	91
Amlodipine Besylate	Amlodipine Besylate	299	90
Oxycodone Hcl	Oxycodone Hcl	243	28
Metformin Hcl	Metformin Hcl	193	56
Gabapentin	Gabapentin	155	43
Pantoprazole Sodium	Pantoprazole Sodium	154	44
Metoprolol Succinate	Metoprolol Succinate	147	48
Lisinopril	Lisinopril	136	43
Zolpidem Tartrate	Zolpidem Tartrate	134	26
Losartan Potassium	Losartan Potassium	131	42
Rosuvastatin Calcium	Rosuvastatin Calcium	121	44
Furosemide	Furosemide	115	33
Diazepam	Diazepam	109	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	105	14
Hydrochlorothiazide	Hydrochlorothiazide	103	26
Omeprazole	Omeprazole	103	29
Meloxicam	Meloxicam	98	25
Albuterol Sulfate Hfa	Albuterol Sulfate	96	30
Clonazepam	Clonazepam	95	18
Montelukast Sodium	Montelukast Sodium	95	26
Metoprolol Tartrate	Metoprolol Tartrate	94	29
Escitalopram Oxalate	Escitalopram Oxalate	92	29
Eliquis	Apixaban	87	28
Sertraline Hcl	Sertraline Hcl	87	22
Tamsulosin Hcl	Tamsulosin Hcl	82	20
Methylprednisolone	Methylprednisolone	81	48
Tramadol Hcl	Tramadol Hcl	73	12
Synthroid	Levothyroxine Sodium	71	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	70	15
Allopurinol	Allopurinol	67	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	65	49
Duloxetine Hcl	Duloxetine Hcl	65	18
Ondansetron Hcl	Ondansetron Hcl	59	suppressed
Lorazepam	Lorazepam	56	13
Clopidogrel	Clopidogrel Bisulfate	53	14
Fluticasone Propionate	Fluticasone Propionate	53	18
Ibuprofen	Ibuprofen	52	11
Warfarin Sodium	Warfarin Sodium	51	suppressed
Ozempic	Semaglutide	43	suppressed
Enalapril Maleate	Enalapril Maleate	41	11
Trazodone Hcl	Trazodone Hcl	40	13
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	38	suppressed
Atenolol	Atenolol	37	12
Azithromycin	Azithromycin	37	26
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	15
Lidocaine	Lidocaine	36	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	35	suppressed
Mirtazapine	Mirtazapine	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Famotidine	Famotidine	32	14
Pravastatin Sodium	Pravastatin Sodium	32	suppressed
Prednisone	Prednisone	32	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	31	23
Ramipril	Ramipril	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Ezetimibe	Ezetimibe	30	suppressed
Carisoprodol	Carisoprodol	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	13
Meclizine Hcl	Meclizine Hcl	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	suppressed
Hydralazine Hcl	Hydralazine Hcl	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Potassium Chloride	Potassium Chloride	28	12
Valsartan	Valsartan	27	suppressed
Xarelto	Rivaroxaban	26	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	25	suppressed
Cefadroxil	Cefadroxil	25	14
Naloxone Hcl	Naloxone Hcl	25	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Finasteride	Finasteride	23	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Tizanidine Hcl	Tizanidine Hcl	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Levofloxacin	Levofloxacin	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Jardiance	Empagliflozin	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Januvia	Sitagliptin Phosphate	20	suppressed
Amantadine	Amantadine Hcl	19	suppressed
Carvedilol	Carvedilol	19	suppressed
Hydrocodone-Ibuprofen	Hydrocodone/Ibuprofen	19	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Amoxicillin	Amoxicillin	18	12
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Ranolazine Er	Ranolazine	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Methocarbamol	Methocarbamol	16	suppressed
Nystatin	Nystatin	16	suppressed
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Halobetasol Propionate	Halobetasol Propionate	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Triazolam	Triazolam	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Linzess	Linaclotide	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Xtampza Er	Oxycodone Myristate	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Testosterone	Testosterone	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Livalo	Pitavastatin Calcium	11	suppressed
Torsemide	Torsemide	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error